Jounce Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2022)

2014 2015 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-36.23-11.19-37.96-23.30-4.005.08-5.65-4.58-1.12-0.00-13.65
Price/Sales ratio
N/AN/A13.985.341.681.953.9715.490.690.001.81
Price/Book Value ratio
-712.247.127.232.291.051.651.171.860.310.001.35
Price/Cash Flow ratio
-25.55-12.412.89-4.22-1.72-9.58-8.92-4.99-1.98-0.00-2.97
Price/Free Cash Flow ratio
-24.41-11.432.93-3.62-1.68-9.28-8.89-4.97-1.92-0.00-2.65
Price/Earnings Growth ratio
N/A-0.050.53-1.04-0.07-0.010.03-0.090.02-0.04-0.56
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/A100%100%100%100%100%100%100%N/A100%
Operating Profit Margin
N/AN/A-38.89%-26.82%-47.99%35.71%-72.37%-338.41%-63.70%-63.70%-6.13%
Pretax Profit Margin
N/AN/A-36.83%-22.90%-41.92%38.45%-70.30%-337.67%-61.93%-61.93%-1.73%
Net Profit Margin
N/AN/A-36.83%-22.95%-41.99%38.42%-70.32%-337.72%-62.09%-62.09%-1.78%
Effective Tax Rate
-54.16%-6.53%-5.56%-0.21%-0.16%0.08%-0.03%-0.01%-0.26%-0.26%-0.04%
Return on Assets
-139.93%-53.85%-5.05%-5.54%-12.76%27.59%-17.95%-35.96%-23.95%-23.95%7.41%
Return On Equity
1965.60%-63.60%-19.06%-9.83%-26.29%32.54%-20.74%-40.60%-27.80%-30.89%3.12%
Return on Capital Employed
-320.83%-65.71%-8.00%-8.20%-21.01%27.58%-20.05%-38.94%-27.64%-27.64%3.28%
Liquidity Ratios
Current Ratio
N/AN/A1.674.082.9312.0610.93N/AN/A8.363.50
Quick Ratio
1.166.801.674.082.9312.0610.9310.098.368.043.50
Cash ratio
0.946.710.490.370.733.697.635.056.386.380.55
Days of Sales Outstanding
N/AN/A6.9590.202.31N/AN/AN/AN/AN/A1.15
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
N/AN/AN/AN/AN/A0.090.060.050.040.130.06
Debt Equity Ratio
N/AN/AN/AN/AN/A0.110.070.060.050.160.08
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.080.060.040.030.030.04
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.100.070.050.050.050.05
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-1.52-1.64-6.09-2.88-2.88-0.76
Company Equity Multiplier
-14.041.183.771.772.051.171.151.121.161.161.61
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/A4.83-1.26-0.97-0.20-0.44-3.10-0.35-0.35-1.12
Free Cash Flow / Operating Cash Flow Ratio
1.041.080.981.161.021.031.001.001.031.031.09
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-1.52-1.64-6.09-2.88-2.88-0.76
Short Term Coverage Ratio
N/AN/AN/AN/AN/A-10.38-8.49-22.59-6.95-6.95-3.47
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A